Tenet rejects Community Health's 'best and final' offer

NewsGuard 100/100 Score

That rejection marked the third since Community Health offered its first unsolicited bid in December.

The Associated Press: Tenet Rejects Higher Community Health Offer
Hospital operator Tenet Healthcare Corp. on Monday rejected Community Health Systems Inc.'s latest buyout offer, which had been increased by about 21 percent. Community's latest offer had been set to expire Monday and had said the latest proposal represented its final offer. Tenet says the offer still undervalues the company. On May 2, Community Health made the increase offer of $4.06 billion, or $7.25 per share in cash. Tenet had already rejected Community Health's $6 per-share offer last month. The companies have been fighting over a deal since last fall. The dispute has since spilled into federal court (5/9).

Bloomberg: Community Health Drops $7.3 Billion Bid for Tenet After Third Rejection
Tenet's refusal earlier yesterday to negotiate marked the third time its board rebuffed Community Health, turning down unsolicited bids in December for $6 a share in cash and stock and an all-cash offer in April. On May 2, Community Health raised its "best and final" offer 21 percent to $7.25 a share and said it would walk away from its effort if Tenet failed to begin "good-faith discussions." Tenet has said since December that the offers undervalued the company, and analysts have told Bloomberg that Tenet should be trading at more than $9 a share (Wechsler and Nussbaum, 5/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois